Skip to main content
Earnings Labs
NewAmsterdam Pharma Company N.V. logo

NewAmsterdam Pharma Company N.V. (NAMS) Earnings

NASDAQ·Healthcare·Biotechnology

$27.25

-0.89%

Mkt Cap $3.26B

EPS — Estimate vs Actual

Mkt Cap

$3.26B

P/E

Fwd P/E

P/S

144.60

Rev TTM

EPS TTM

-$1.81